Literature DB >> 22455622

Genetically divergent methicillin-resistant Staphylococcus aureus and sec-dependent mastitis of dairy goats in Taiwan.

Chishih Chu1, Changyou Yu, Yanhaui Lee, Yaochi Su.   

Abstract

BACKGROUND: Widespread in the environment, Staphylococcus spp. infect animals and humans as normal flora or pathogens. By extending our recent report of multi-drug resistant (MDR) S. aureus in dairy goats, this study investigated the staphylococcal infection and characterized the MDR-S. aureus and methicillin-resistant S. aureus (MRSA) isolates collected from goats in 2008 to elucidate the appearance of MRSA in goats and the mastitis associated staphylococcus enterotoxin (SE) types. A total of 555 samples were collected from six goat parts and three environmental sources among four dairy goat farms in southern Taiwan. Coagulase-positive and negative Staphylococcus spp. (CPS and CNS, respectively) were also identified. Furthermore, predominant SE genes of nine enterotoxin genes sea through sej along with antimicrobial resistance and genetic variations were determined.
RESULTS: In total, 137 staphylococcal strains were identified and found predominantly in milk, and in the vagina, anus, and nasal cavity. The most prevalent species was S. lentus, followed by S. aureus, S. epidermidis, and S. xylosus. Enterotoxin genes were not identified in any CNS isolates, however sec and see were identified only in S. aureus associated with mastitis in goat. In compared to the isolates from 2006 to 2007, 27 S. aureus isolates from 2008 were found to be more resistant to ampicillin, cephalothin, oxacillin, oxytetracycline, penicillin G, and tetracycline. Eleven MRSA isolates were identified and belonged to SCCmec type III (nine isolates) as the major type and SCCmec type II (two isolates). These MRSA isolates revealed pulse-field gel electrophoresis (PFGE) pattern A (five isolates), C (one isolate), and D (one isolate) of human isolates. The other two isolates without pulsotypes belonged to ST59.
CONCLUSION: The prevalence and infection sites of CNS differed from those of CPS. Genetic analyses indicated that genetic divergence, possible zoonotic transfer of MRSA, and the involvement of sec as important virulence factors for of S. aureus that lead to mastitis in goats.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22455622      PMCID: PMC3353860          DOI: 10.1186/1746-6148-8-39

Source DB:  PubMed          Journal:  BMC Vet Res        ISSN: 1746-6148            Impact factor:   2.741


Background

Important pathogenic species of coagulase-positive and negative Staphylococcus (CPS and CNS, respectively) are S. aureus and S. epidermidis, respectively, which are frequently isolated from the environment and infected animals and humans [1,2]. S. aureus can cause severe blood infections and necrotizing fasciitis in humans, wound infection and mastitis in cattle, horses, pigs, and goats, exudative epidermitis in pigs, pyoderma in horses, dogs, and cats, pyemic sheep [2,3]. As an opportunistic pathogen, CNS occasionally cause subclinical or clinical mastitis. For example, in cattle mastitis can be caused by S. capitis, S. chromogenes, S. cohnii, S. epidermidis, S. haemolyticus, S. hominis, S. simulans, S. warneri, S. hyicus, and S. caseolyticus; in goats by S. caprae; and in cattle and sheep by S. xylosus [2]. However, CNS can damage breast tissue to increase the somatic cell counts and decrease milk quality and production [4]. The identification of CNS species is essential to determine their pathogenicity and to develop management practices to prevent mastitis. Due to difficult and expensive procedures for identifying these organisms, many laboratories do not perform these assays. As opportunistic pathogens, S. aureus and S. epidermidis can also cause bacteremia, subacute endocarditis, and can form biofilms on heart valve prostheses, shunts, total joint arthroplasty or surgical sutures in humans [5]. Some S. aureus isolates possess a staphylococcal enterotoxin (SE), which is a virulence factor for foodborne disease and can form several products from SE genes, designates sea - seu [6,7]. These SE genes are associated with host-specific infection, such as seb for foodborne infection in humans, sea for bovine infection [8], and sec for mastitis in goats and bovine [9]. However, more than 10 SE genes were identified in isolates obtained from goats [7]. As the most prevalent pathogen in both hospitals and communities, S. aureus can become methicillin (oxacillin)-resistant S. aureus (MRSA/ORSA) by the introduction of an exogenous mobile staphylococcal chromosomal cassette, mec (SCCmec), encoding a low-affinity penicillin-binding protein 2a responsible for methicillin/oxacillin resistance [10-14]. Based on variations in the ccr operon and mec complexes, at least seven SCCmec types have been identified [14-16]. Moreover, methicillin-resistant CNS has been identified in animals [17]. The extensive use of antibiotics in hospitals and animals has increased the emergence of MDR Staphylococcus [1]. Since the emergence of MRSA isolated from humans in the 1960s [18], MRSA has been frequently isolated in hospitals, dogs, and horses as a zoonotic pathogen [17,19,20]. Our recent study characterized MDR S. aureus from dairy goats in 2006-2007 and no MRSA was isolated [21]. The current study investigated the prevalent Staphylococcus spp. and characterized the MDR-S. aureus and MRSA isolates collected from goats in 2008 by nucleotide sequencing, pulse-field gel electrophoresis (PFGE) analysis and polymerase chain reaction (PCR) analysis to elucidate the origins of MRSA isolates and the SE types associated with mastitis in goats.

Results

Identification of staphylococcus species

In total, 555 samples were collected from six bodily regions of dairy goats and three environmental sources in 2008. Among 45.4% (252/555) samples with bacterial growth on blood agar, 137 staphylococcal strains and 115 non-staphylococcal strains were identified. Five major Staphylococcus spp. were identified and listed in decreasing order of isolate number: S. lentus (31), S. aureus (27), S. epidermidis (23), S. xylosus (17) and S. caprae (3), and others (36).

Prevalent staphylococcus species in different sampling locations and farms

Staphylococcal species were frequently isolated from milk, anus, vagina, nasal cavity, and udders (Table 1). However, the predominant infection sites differed between S. aureus and CNS. On average, the prevalence of S. aureus was 18.9 and 0.7% for goats and environmental samples, respectively, and differed among farms and body regions of goats (Table 1). In contrast to being absent in the anus and dorsum, S. aureus was predominant in the nasal cavity (12), vagina (9), and milk (4); in addition, CNS was prevalent in the milk (54), vagina (26), and anus (26).The highest prevalence of S. aureus was found in Farm A, followed by Farms D, C and B. In contrast, the highest prevalence of CNS was found in goats on Farm D followed by Farms C, B, and A.
Table 1

Prevalence of Staphylococcus spp. in different goat farms

Sample siteFarm A (%)Farm B (%)Farm C (%)Farm D (%)Total(%)SA(%)CNSb(%)

SACNSSACNSSACNSSACNS
Dorsum0(0/21)0(0/21)0(0/21)0(0/21)0(0/20)0(0/20)0(0/11)0(0/11)0(0/73)0(0/137)a0(0/137)
Vagina10.0(2/20)10.0(2/20)9.5(2/21)19.0(4/21)15.0(3/20)25.0(5/20)18.2(2/11)45.5(5/11)34.7(25/72)6.6(9/137)12.4(16/137)
Anus0(0/20)20.0(4/20)0(0/21)38.1(8/21)0(0/20)45.0(9/20)0(0/11)45.5(5/11)36.1(26/72)0(0/137)19.0(26/137)
Udder0(0/20)15.0(3/20)0(0/21)9.5(2/21)5.0(1/20)5.0(1/20)0(0/11)9.1(1/11)11.1(8/72)0.7(1/137)5.1(7/137)
Nasal cavity35.0(7/20)0(0/20)9.5(2/21)9.5(2/21)5.0(1/20)10.0(2/20)18.2(2/11)36.4(4/11)27.8(20/72)8.8(12/137)5.8(8/137)
Milk2.5(1/40)20.0(8/40)2.4(1/42)33.3(14/42)2.5(1/40)42.5(17/40)4.3(1/23)52.2(12/23)37.9(55/145)2.9(4/137)39.4(51/137)
Apparatus0(0/15)6.7(1/15)0(0/8)0(0/8)0(0/6)0(0/6)0(0/5)0(0/5)2.9(1/34)0(0/137)0.7(1/137)
Bulk tank50.0(1/2)0(0/2)0(0/2)0(0/2)0(0/2)50.0(1/2)33.3(2/6)0.7(1/137)0.7(1/137)
Water0(0/3)0(0/3)0(0/2)0(0/2)0(0/2)0(0/2)0(0/2)0(0/2)0(0/9)0(0/137)0(0/137)

Total6.8(11/161)11.2(18/161)3.1(5/159)18.9(30/159)4.0(6/150)23.3(35/150)5.9(5/85)31.8(27/85)24.7(137/555)19.7(27/137)80.3(110/137)

a137 isolates consisted of 27 S. aureus isolates and 110 CNS isolates

bCNS: catalase-negative Staphylococcus spp

Prevalence of Staphylococcus spp. in different goat farms a137 isolates consisted of 27 S. aureus isolates and 110 CNS isolates bCNS: catalase-negative Staphylococcus spp

Antimicrobial susceptibility

Fifteen antimicrobial agents were used to characterize S. aureus strains and could be divided into 13 antibiograms. Nearly all isolates were susceptible to enrofloxacin, gentamycin, neomycin, and vancomycin; in addition, over 60% of the isolates were also resistant to penicillin (P), ampicillin (A), cephalothin, tetracycline (T), and oxytetracycline (Ot) (Table 2). In this study, 11 (40.7%) MRSA isolates were identified in nasal cavity, vagina, and goat milk only. Isolates from the nasal cavity exhibited the highest antimicrobial resistance. Compared with the antimicrobial resistance found for isolates identified in 2006-2007, isolates from 2008 revealed an increase in resistance to ampicillin, bacitracin (B), cloxacin (Cl), oxacillin (Ox), penicillin G, and streptomycin (S) (Table 2). Although 88.9% of isolates were resistant to more than one antimicrobial agent; the most prevalent antibiograms were AOtPT (29.6%, 8/27) and ABClOtOxPST (25.9%, 7/27). The antibiogram number varied among farms from six in Farm A to five in Farm B, four in Farm D and two in Farm C. Differences in antibiograms and their number may indicate the different bacterial sources in each farm. The minimum inhibitory concentrations (MIC) of 11 MRSA isolates to methicillin ranged from 16 to 256 μg/mL, and varied among farms and bodily region. The highest MIC was found in isolates collected from the nasal cavity (64-256 μg/mL), followed by goat milk (64 μg/mL), and vagina (16-64 μg/mL).
Table 2

Susceptibility to 15 antimicrobials for Staphylococcus aureus isolated from the goat nasal cavity, vagina, and milk

Antimicrobial2006-2007Location (2008)

TotalGoat milkNasal cavityVagina
Penicillin G57.0(49/86)85.2(23/27)50.0(1/2)100(12/12)88.9(8/9)
Ampicillin57.0(49/86)81.5(22/27)100(2/2)100(12/12)66.7(6/9)
Bacitracin0(0/86)29.6(8/27)0(0/2)50.0(6/12)22.2(2/9)
Cephalothin0(0/86)70.4(19/27)50(1/2)66.7(8/12)77.8(7/9)
Furoxime0(0/86)14.8(4/27)50.0(1/2)8.3(1/12)11.1(1/9)
Cloxacillin1.2(1/86)48.1(13/27)50.0(1/2)58.3(7/12)44.4(4/9)
Enrofloxacin2.3(2/86)0(0/27)0(0/2)0(0/12)0(0/9)
Gentamicin14.0(12/86)7.4(2/27)50.0(1/2)0(0/12)11.1(1/9)
Neomycin10.5(9/86)7.4(2/27)50.0(1/2)0(0/12)11.1(1/9)
Oxacillin0(0/86)40.7(11/27)50.0(1/2)58.3(7/12)33.3(3/9)
Oxytetracycline72.1(62/86)66.7(18/27)100(2/2)83.3(10/12)44.4(4/9)
Streptomycin22.1(19/86)40.7(11/27)50.0(1/2)41.7(5/12)44.4(4/9)
Tetracycline69.8(60/86)74.1(20/27)100(2/2)83.3(10/12)66.7(6/9)
Sulfamethoxazole/Trimethoprim2.3(2/86)7.4(2/27)50.0(1/2)8.3(1/12)0(0/9)
Susceptibility to 15 antimicrobials for Staphylococcus aureus isolated from the goat nasal cavity, vagina, and milk

Staphylococcal enterotoxin types

Of the nine enterotoxin genes examined, only sec and see were identified in S. aureus isolates and no SE genes were found in 71 CNS strains (Table 3). Eight out of 10 S. aureus strains isolated from milk of 15 goats with mastitis were shown to possess sec. PCR-restriction fragment length polymorphism (RFLP) analysis of sec PCR products revealed an identical AluI restriction pattern for all strains. In 27 S. aureus bovine strains, only sea was identified in three strains.
Table 3

Prevalence of enterotoxin genes in different Staphylococcus spp

Enterotoxin genesPositive rate (%)

GoatBovine


S. aureus (n = 113)aS. aureus (n = 10)bCNS (n = 71)S. aureus (n = 27)c
sea0 (0/113)0 (0/10)0 (0/71)11.1 (3/27)
seb0 (0/113)0 (0/10)0 (0/71)0 (0/27)
sec22.1 (25/113)80.0 (8/10)0 (0/71)0 (0/27)
sed0 (0/113)0 (0/10)0 (0/71)0 (0/27)
see0.9 (1/113)0 (0/10)0 (0/71)0 (0/27)
seg0 (0/113)0 (0/10)0 (0/71)0 (0/27)
seh0 (0/113)0 (0/10)0 (0/71)0 (0/27)
sei0 (0/113)0 (0/10)0 (0/71)0 (0/27)
sej0 (0/113)0 (0/10)0 (0/71)0 (0/27)

a113 strains comprised 27 strains in 2008 and 86 strains in 2006-2007

b10 S. aureus strains isolated from 15 goat mastitis samples

c27 S. aureus strains isolated from cattle with mastitis

Prevalence of enterotoxin genes in different Staphylococcus spp a113 strains comprised 27 strains in 2008 and 86 strains in 2006-2007 b10 S. aureus strains isolated from 15 goat mastitis samples c27 S. aureus strains isolated from cattle with mastitis

Characterization of oxacillin-resistant S. aureus

PCR amplification of 11 MRSA isolates identified SCCmec type III in nine isolates from Farms A (8) and B (1), and SCCmec type II in two isolates found in Farms B (1) and D (1) (Table 4). Two isolates could not be pulsotyped and six pulsotypes were determined (Figure 1). Four pulsotypes were identified in six isolates of Farm A, revealing identical patterns as pulsotypes A, C, and D in human isolates previously identified in Taiwan [22]. The remaining isolates belonged to pulsotypes VIA and VIB (no similar pulsotypes as human isolates) in Farm B and pulsotype V (pulsotype A of human isolate) in Farm D. Multi-locus sequence typing (MLST) analysis indicated that two isolates for which no pulsotype could be determined were ST59, the common MLST types of human isolates. Phylogenetic analysis of sec showed that sequence similarity ranged from 94.8-100% (Figure 2).
Table 4

Characterization of 11 oxacillin-resistant S.aureus strains

StrainsmecASCCmec typePulsotypeaFarmsbPulsotype of human strainc
N0119+IIIND (ST59)dA
N0207+IIIND (ST59)A
N0229+IIIIAA
N0262+IIIIIAC
N6292+IIIIIIAA
N6294+IIIIAA
V34+IIIIVAD
V6292+IIIIAA
V17+IIIVIAB
N9+IIVIBB
MR28+IIVDA

aND: DNA could not be digested by restriction enzyme SmaI

bLetters represent farms where samples were acquired

cPulsotypes were determined as previously reported by Huang et al. [22]

d ST determined based on the MLST website http://saureus.mlst.net/

Figure 1

PFGE patterns of . Lanes 1, 4 and 7: pulsotype I; lane 2: pulsotype II, lane 3: pulsotype III, lane 5: pulsotype IV, lane 6: pulsotype V; lane 8: pulsotype VIA; and lane 9: pulsotype VIB. M: λ DNA marker.

Figure 2

Phylogenetic tree of . The tree was constructed using the Megalign program of the Lasergene software. Scale bar represents number of nucleotide substitutions per? bases.

Characterization of 11 oxacillin-resistant S.aureus strains aND: DNA could not be digested by restriction enzyme SmaI bLetters represent farms where samples were acquired cPulsotypes were determined as previously reported by Huang et al. [22] d ST determined based on the MLST website http://saureus.mlst.net/ PFGE patterns of . Lanes 1, 4 and 7: pulsotype I; lane 2: pulsotype II, lane 3: pulsotype III, lane 5: pulsotype IV, lane 6: pulsotype V; lane 8: pulsotype VIA; and lane 9: pulsotype VIB. M: λ DNA marker. Phylogenetic tree of . The tree was constructed using the Megalign program of the Lasergene software. Scale bar represents number of nucleotide substitutions per? bases.

Discussion

CNS strains S. lentus, S. epidermidis, S. xylosus, and S. caprae, and S. aureus were identified as the predominant species infecting goats in this study. S. aureus and CNS differed in prevalence and bodily location in goats (Table 1). Additionally, CNS and S. aureus accounted for 38.2 and 11% of infections, respectively, in the milk of goats with mastitis [23], and 2.6% (35/1,372) and 17.3% (237/1,372), respectively, in the milk of dairy cows and goats in Taiwan [24]. In animals, the prevalence of S. aureus differed among countries, such as 2.2% in the United Kingdom [25], 6.7% in Canada [26], 9.1% in USA [27], 24.2% in Ethiopia [28], 29.6% in Korea [29], and 32.9% in Uruguay [30]. However, S. aureus accounts for 18.7% (64/342) of staphylococcal infections in goats [7]. In Taiwan, S. aureus infection in goats increased from 1.7% (12/706) [24] up to 2.5% (86/3,427) [31] and 4.9% (27/555) in this study. Sanitation may be another important factor that leads to an increase in S. aureus infection. Indeed, sanitation could reduce the S. aureus infection from 6.6 to 0.6% or from 14.6 to 3.0% [32,33]. In Taiwan, S. aureus infection in milk ranged from 0-5.2% among farms [21]. In the present study, the prevalence ranged from 3.1 to 6.8% for S. aureus and from 11.2 to 31.8% for CNS among farms, suggesting that CNS infection is more common in goats. Early reports indicated that staphylococcal infections in goat bodily regions differed and ranged from 6.1% (21/342) in the armpits up to 70.8% (242/342) on the skin of udders and mamilla, and contributed to only 0.7% contamination of the apparatus [7]. Although lacking statistical analysis in this study, Staphylococcus was identified in 42.3% (58/137) and 5.8% (8/137) of milk and udders, respectively (Table 1), suggesting that Staphylococcus is a major bacterial cause of mastitis in goats that can then infect humans through unsanitary milk. As an important virulence factor causing foodborne disease in humans, predominant SE genes are associated with outbreaks in certain countries, such as sea in France [34], seb in eastern Slovakia, Tehran, and Japan [35-37], sec-2 and sec-3 in Taiwan [38]. Furthermore, particular sec types is also associated with food-related Staphylococcus spp. [39], in S. aureus, and CNS isolated from the milk of sheep [7,40], and in S. aureus collected from sheep or cows with mastitis [41]. Additionally, sea was determined to be the major type in S. aureus from cows with mastitis [8]. As shown in Table 3, sec and sea were the major SE genotypes found in goats and cows, respectively, and sec was associated with mastitis in goats. These data confirmed the importance of the sec gene involved in goat mastitis pathogenesis [42]. In cattle, the SEC toxin (not toxic shock syndrome toxin type 1 or TSST-1) was previously shown to significantly increase somatic cell counts and enhance the severity of the mastitis in acute mastitis [43]. Although SE genes have been found in CNS species, such as S. xylosus, S. warneri, and S. chromogenes isolated from cows and goats [7,40,44,45], they were only identified in CPS but not CNS isolated previously in Taiwan [46,47] and in the present study (Table 3). As an opportunistic pathogen that can cause mastitis in cattle and goats [1,21,48,49], S. aureus infection can also cause clinical symptoms in cattle [50] but is typically asymptomatic in goats [21,48]. Using penicillin, ampicillin, and tetracycline antibiotics to treat bacterial infections in animals often increases resistance to these antibiotics. In cattle, S. aureus or other Staphylococcus spp. causing mastitis were more resistance to penicillin and ampicillin, streptomycin, tetracycline, and oxytetracycline [1,24,49,51]. Our data showed an increased resistance to penicillin, ampicillin, cloxacillin, and cephalothin from 2006 to 2008, in addition to the appearance of MRSA isolates from goats in 2008 (Table 2). Furthermore, the MRSA isolates identified in this study belonged to the major nosocomial SCCmec types: SCCmec type II and III [52,53]. Zoonotic transfer of MRSA has been reported between horses and humans in the USA [20,54], between cattle and humans in Korea [55], and between livestock and humans in Taiwan [56,57]. Our data indicate that MRSA isolates may have been acquired from humans or transmitted from different goat breeding farms. PFGE analysis is typically performed to trace the pathogens responsible for outbreaks. Containing a thick cell wall, S. aureus must be treated with lysostaphin, not lysozyme, to break the pentaglycine linkage within the peptidoglycan [58,59]. For genomic analysis of S. aureus, genomic DNA cannot be digested by restriction enzyme SmaI and diverse genomic variations in size [60] limit the utility of PFGE analysis. However, pulsotypes appear to correlate with human disease. Pulsotype D S. aureus is associated with more severe symptoms than pulsotype type C bacteria that only cause mild symptoms [50]. In Taiwan, MRSA accounts for 53-83% of S. aureus isolates from hospitals [61] and the major pulsotypes of human MRSA are pulsotype A, followed by types C and D [22]. In this study, pulsotype A was also the most prevalent type of goat MRSA isolate (Figure 1, Table 4). Additionally, PFGE analysis also revealed diverse sources of MRSA in Farm A and a single origin in Farms B and D (Table 4).

Conclusion

The current study was the first report of the appearance of MRSA strains and sec-associated mastitis in goats from Taiwan. Analysis of SCCmec types and pulsotypes revealed that the genetically diverse MRSA strains might have been acquired from humans or transferred from different goat breeding farms.

Methods

Source of bacterial isolates

Samples were acquired aseptically according to the procedure described by the National Mastitis Council (NMC) with some modification [62]. Informed consent was obtained from all farm owners prior to the start of this study. A total of 555 samples were collected from the milk, anus, dorsum, nasal cavity, udders, and vagina of goats, in addition to milking apparatus, bulk tank, and water of environments at four different goat farms in Taiwan during 2008. Isolates (n = 137) were characterized by culture on blood agar [63], morphology, Gram stain, catalase test, and growth on Staphylococcus medium No. 110 (Oxoid, Basingstoke, UK). Furthermore, Staphylococcus species were biotyped according to method of Myllys et al. [64] using the API Staph identification kit (BioMerieux, Marcy l'Etoile, France). Additionally, 86 isolates collected in 2006-2007 were compared with those isolated in 2008. CPS (BCRC 14958, ATCC 27664) and CNS (BCRC 15228) strains were purchased from the Bioresource Collection and Research Center (BCRC, Taiwan). Twenty-seven S. aureus strains isolated from cattle with mastitis were kindly provided by Professor Shih-Te Chuang, (College of Veterinary Medicine, National Chung Hsing University, Taiwan) for examination of enterotoxin genotypes. Human isolates were kindly provided by Professor Chishih Chu, (the Department of Microbiology, Immunology, and Biopharmaceuticals, National Chiayi University). The use of all bacteria was supervised by the Biological Security Committee of National Chiayi University in accordance with the laws of Taiwan. The protocols and regulations used during the study were performed according to the guidelines of"Animal Use Protocol, the Institutional Animal Care and Use Committee (IACUC), National Chiayi University" with great care for animal welfare and adherence to the law.

Antimicrobial susceptibility test

The disc diffusion method and the guidelines of the Clinical and Laboratory Standards Institute (CLSI) standards and the manufacturer were used to determine the susceptibility of each isolate to ampicillin (AMP; 10 μg), bacitracin (BAC; 10 units), oxacillin (OXA; 1 μg), cefuroxime (CXM; 30 μg), cephalothin (CEP; 30 μg), cloxacillin (CLO; 5 μg), enrofloxacin (ENR; 5 μg), gentamicin (GEN; 10 μg), neomycin (NEO; 30 μg), oxytetracycline (OXY; 30 μg), penicillin G (PEN; 10 U), streptomycin (STR; 10 μg), sulfamethoxazole/trimethoprim (Sxt; 23.75 μg for S and 1.25 μg for t), tetracycline (TET; 30 μg), and vancomycin (VAN; 30 μg) [65]. Results of the antimicrobial susceptibility were also validated using Escherichia coli (ATCC No. 25922). Bacto discs were purchased from Becton Dickinson (Sparks, MD, USA). Finally, MIC to oxacillin of each ORSA isolate was determined by Etest (AB Biodisk, Solna, Sweden).

SCCmec typing

DNA templates of MRSA isolates were prepared for PCR amplification using the QIAamp DNA Mini Kit (Qiagen, Valencia, CA, USA). Table 5 lists the primers used to identify mecA and the SCCmec types [52,66,67]. A 50-μL PCR reagent included 5 μL of DNA template, 20 μM of each primer, 0.2 mM dNTPs, 5 μL of 10× PCR reaction buffer, 1.4 U Taq DNA polymerase, and 33.3 μL distilled water. The PCR conditions were a initial denaturation at 94°C for 4 min, followed by 30 cycles of 94°C for 30 s, 53°C for 30 s, and 72°C for 1 min and a final extension at 72°C for 4 min. PCR products were separated by 2% agarose at 50 V for 1 hr and visualized under ultraviolet illumination after ethidium bromide (EtBr) staining.
Table 5

Primers used for amplification of SCCmec type and enterotoxin gene

LocusPrimerOligonucleotide sequence (5'-3')Amplicon size (bp)SCCmec typeeReference
SCCmec

ACIF2 F2 aTTCGAGTTGCTGATGAAGAAGG495I[17]
CIF2 R2 aATTTACCACAAGGACTACCAGC

BKDP F1 bAATCATCTGCCATTGGTGATGC284II[18]
KDP R1 bCGAATGAAGTGAAAGAAAGTGG
CMECI P2 bATCAAGACTTGCATTCAGGC209II, III
MECI P3 bGCGGTTTCAATTCACTTGTC

DDCS F2aCATCCTATGATAGCTTGGTC342I, II, IV[17]
DCS R1aCTAAATCATAGCCATGACCG
ERIF4 F3cGTGATTGTTCGAGATATGTGG243III[18]
RIF4 R9cCGCTTTATCTGTATCTATCGC
FRIF5 F10cTTCTTAAGTACACGCTGAATCG414III
RIF5 R13cGTCACAGTAATTCCATCAATGC
GIS431 P4bCAGGTCTCTTCAGATCTACG381
pUB110 R1bGAGCCATAAACACCAATAGCC
HIS431 P4cCAGGTCTCTTCAGATCTACG303
pT181 R1cGAAGAATGGGGAAAGCTTCAC
mecAMECA P4dTCCAGATTACAACTTCACCAGG162Internal control[16]
MECA P7dCCACTTCATATCTTGTAACG

Staphylococcal enterotoxin (SEs)
seaESA 1ACGATCAATTTTTACAGC544[68]
ESA 2TGCATGTTTTCAGAGTTAATC
sebESB 1GAATGATATTAATTCGCATC416[69]
ESB 2TCTTTGTCGTAAGATAAACTTC
secESC 1GACATAAAAGCTAGGAATTT257[70]
ESC 2AAATCGGATTAACATTATCCA
sedESD 1TTACTAGTTTGGTAATATCTCCTT334[71]
ESD 2CCACCATAACAATTAATGC
seeESE 1ATAGATAAAGTTAAAACAAGCAA170[72]
ESE 2TAACTTACCGTGGACCC
segESG 1ACGTCTCCACCTGTTGAAGG400[73]
ESG 2TGAGCCAGTGTCTTGCTTTG
sehESH 1TCACATCATATGCGAAAGCAG357[74]
ESH 2TAGCACCAATCACCCTTTCC
seiESI 1TGGAACAGGACAAGCTGAAA467[73]
ESI 2TAAAGTGGCCCCTCCATACA
sejESJ 1CAGCGATAGCAAAAATGAAACA426[75]
ESJ 2TCTAGCGGAACAACAGTTCTGA
SecfsetC-FsetC-RAGATTTAGCAAAGAAGTACAAAGATGAAGGTGGACTTCTATCTTCACACTT490[76]

aRelative to accession no. AB033763, SCCmec type I

bRelative to accession no. D86934, SCCmec type II

cRelative to accession no. AB037671, SCCmec type III

dRelative to accession no. Y00688, mecA gene.

eLoci G and H were included to distinguish variants IA from I and IIIA from III, respectively

fPrimer pair used for PCR-RFLP

Primers used for amplification of SCCmec type and enterotoxin gene aRelative to accession no. AB033763, SCCmec type I bRelative to accession no. D86934, SCCmec type II cRelative to accession no. AB037671, SCCmec type III dRelative to accession no. Y00688, mecA gene. eLoci G and H were included to distinguish variants IA from I and IIIA from III, respectively fPrimer pair used for PCR-RFLP

PCR identification of SE types and PCR-RFLP analysis

Staphylococcal enterotoxin genes, sea-sej, were amplified by PCR using primers listed in Table 5[68-76]. 50-μL PCR reagent was described earlier. The cycling conditions for multiplex PCR were 5 min at 94°C for initial denaturation, followed by 30 cycles of 1 min at 94°C, 30 s at 60°C, 1 min at 72°C and a final extension at 72°C for 10 min to amplify sea - see. For amplification of seg-sej, initial denaturation was performed for 3 min at 94°C, followed by 30 cycles of 30 s at 94°C, 30 s at 60°C, and 30 s at 72°C and a final extension at 72°C for 10 min. PCR products of sec were purified from agarose gels using the Gene-Spin-V2 Miniprep purification kit (Protech Technology, Solon, OH, USA), and the purified products were digested with restriction enzyme AluI and separated by 1% agarose gel run at 50 V for 1 hr. Furthermore, the purified PCR products were sequenced and analyzed using the Megalign program of the Lasergene software (DNAstar, Madison, Wisconsin, USA).

Genetic typing

The genotype of each MRSA isolate was determined by restriction enzyme SmaI-digested PFGE analysis, as previously described [77]. Briefly, whole-cell embedded agarose plugs were digested with SmaI and then resolved by a CHEF DR-III apparatus (Bio-Rad, Hercules, CA, USA). Finally, the MRSA isolate BCRC 15211 was used as the standard size marker. Pulsotypes and MLST types of MRSA were determined based on the method described by Enright et al. [78] and analysis of MLST databases, respectively.

Abbreviations

AMP: ampicillin; BAC: bacitracin; CEP: cephalothin; CLO: cloxacillin; CNS: coagulase-negative Staphylococcus; CPS: coagulase-positive Staphylococcus; CXM: cefuroxime; ENR: enrofloxacin; EtBr: ethidium bromide; GEN: gentamicin; MDR: multi-drug resistance; MIC: minimum inhibitory concentration; MRSA/ORSA: methicillin/oxacillin-resistant Staphylococcus aureus; NEO: neomycin; OXA: oxacillin; OXY: oxytetracycline; PCR-RFLP: polymerase chain reaction- restriction fragment length polymorphism; PEN: penicillin G; PFGE: pulsed-field gel electrophoresis; SCCmec: staphylococcal cassette chromosome mec; SE: staphylococcal enterotoxin; STR: streptomycin; Sxt: sulfamethoxazole/trimethoprim; TET: tetracycline; VAN: vancomycin.

Authors' contributions

CC instructed the molecular genetics and phylogenetic studies, and edited the manuscript. CYY designed experiments and assisted in data analysis. YHL performed the experiments. YCS coordinated and designed the experiments, and prepared the manuscript. All authors read and approved the final manuscript.

Authors' information

Chishih Chu is a Professor in the Department of Microbiology, Immunology, and Biopharmaceuticals. Changyou Yu is a Professor in the Department of Veterinary Medicine. Yanhaui Lee was a Master student in the Department of Veterinary Medicine. Yaochi Su is an Associate Professor in the Department of Veterinary Medicine, National Chiayi University, Taiwan, Republic of China.
  61 in total

1.  Modified multiplex PCR method for detection of pyrogenic exotoxin genes in staphylococcal isolates.

Authors:  Astrid Løvseth; Semir Loncarevic; Knut G Berdal
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

2.  Nucleotide sequence of the type A staphylococcal enterotoxin gene.

Authors:  M J Betley; J J Mekalanos
Journal:  J Bacteriol       Date:  1988-01       Impact factor: 3.490

3.  Nucleotide sequence of the staphylococcal enterotoxin C1 gene and relatedness to other pyrogenic toxins.

Authors:  G A Bohach; P M Schlievert
Journal:  Mol Gen Genet       Date:  1987-08

4.  Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations.

Authors:  F F Barrett; R F McGehee; M Finland
Journal:  N Engl J Med       Date:  1968-08-29       Impact factor: 91.245

5.  Nucleotide sequence of the enterotoxin B gene from Staphylococcus aureus.

Authors:  C L Jones; S A Khan
Journal:  J Bacteriol       Date:  1986-04       Impact factor: 3.490

6.  Evolution of an inducible penicillin-target protein in methicillin-resistant Staphylococcus aureus by gene fusion.

Authors:  M D Song; M Wachi; M Doi; F Ishino; M Matsuhashi
Journal:  FEBS Lett       Date:  1987-08-31       Impact factor: 4.124

7.  A quantitative study of enterotoxin production by sheep milk staphylococci.

Authors:  L Bautista; P Gaya; M Medina; M Nuñez
Journal:  Appl Environ Microbiol       Date:  1988-02       Impact factor: 4.792

8.  Herd management and prevalence of mastitis in dairy herds with high and low somatic cell counts.

Authors:  R J Erskine; R J Eberhart; L J Hutchinson; S B Spencer
Journal:  J Am Vet Med Assoc       Date:  1987-06-01       Impact factor: 1.936

9.  Penicillin-binding proteins of beta-lactam-resistant strains of Staphylococcus aureus. Effect of growth conditions.

Authors:  P E Reynolds; D F Brown
Journal:  FEBS Lett       Date:  1985-11-11       Impact factor: 4.124

10.  Molecular typing of enterotoxigenic Staphylococcus aureus isolated from bovine mastitis in Korea.

Authors:  Suk-Kyung Lim; Yi-Seok Joo; Jin-San Moon; Ae-Ri Lee; Hyang-Mi Nam; Sung-Hwan Wee; Hong-Bum Koh
Journal:  J Vet Med Sci       Date:  2004-05       Impact factor: 1.267

View more
  3 in total

1.  Potential use of Bacillus thuringiensis bacteriocins to control antibiotic-resistant bacteria associated with mastitis in dairy goats.

Authors:  A J Gutiérrez-Chávez; E A Martínez-Ortega; M Valencia-Posadas; M F León-Galván; N M de la Fuente-Salcido; D K Bideshi; J E Barboza-Corona
Journal:  Folia Microbiol (Praha)       Date:  2015-05-29       Impact factor: 2.099

2.  Prevalence and molecular characterization of Staphylococcus aureus isolated from goats in Chongqing, China.

Authors:  Zuoyong Zhou; Mengsi Zhang; Hexian Li; Haoyue Yang; Xiaoxia Li; Xinyue Song; Zhiying Wang
Journal:  BMC Vet Res       Date:  2017-11-25       Impact factor: 2.741

3.  Nasal Carriage of Staphylococcus aureus : Frequency and Antibiotic Resistance in Healthy Ruminants.

Authors:  Heidar Rahimi; Habib Dastmalchi Saei; Malahat Ahmadi
Journal:  Jundishapur J Microbiol       Date:  2015-10-12       Impact factor: 0.747

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.